Lv1
28 积分 2024-12-30 加入
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial
4天前
已完结
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
16天前
已完结
Synthesis and Bioactivity Investigation of the Individual Components of Cyclic Lipopeptide Antibiotics
1个月前
已完结
New advances in small molecule drugs targeting NMDA receptors
1个月前
已完结
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
1个月前
已完结
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial
1个月前
已完结
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
1个月前
已完结
Unexplained or Refractory Chronic Cough in Adults
1个月前
已完结
Targeted alpha therapy (r)evolution: emerging nuclides for clinical applications
1个月前
已完结
Airway sensory neurobiology and TRP channels in chronic cough: mechanisms, cough hypersensitivity, and therapeutic translation
1个月前
已关闭
皖公网安备34019202002308
